Kristen Yen - 25 Jan 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer title: Senior Vice President, Clinical Operations
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
25 Jan 2024
Net transactions value
-$19,175
Form type
4
Filing time
29 Jan 2024, 17:47:38 UTC
Previous filing
08 Jan 2024
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale $19,175 -397 -1.5% $48.30 25,640 25 Jan 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Remarks:

Officer title: Senior Vice President, Clinical Operations